Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope
- 15 August 2006
- journal article
- research article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 111 (3) , 209-216
Abstract
In patients with neurocardiogenic syncope, head-up tilt often evokes acute loss of consciousness accompanied by vasodilatation, increased plasma adrenaline and systemic hypotension. Since hypotension increases adrenaline levels and adrenaline can produce skeletal muscle vasodilatation by activating β2 receptors, adrenaline might induce a positive feedback loop precipitating circulatory collapse. We hypothesized that propranolol, a non-selective β-blocker, would prevent adrenaline-induced vasodilatation and thereby prevent syncope. Eight subjects with recurrent neurocardiogenic syncope and previously documented tilt-induced syncope with elevated plasma adrenaline levels participated in the present study. Subjects underwent tilt table testing after receiving oral propranolol or placebo in a double-blind randomized crossover fashion. Haemodynamic and neurochemical variables were measured using intra-arterial monitoring, impedance cardiography, arterial blood sampling and tracer kinetics of simultaneously infused [3H]noradrenaline and [3H]adrenaline. The occurrence of tilt-induced neurally mediated hypotension and syncope, duration of tilt tolerance, extent of the decrease in SVRI (systemic vascular resistance index) and magnitude of plasma adrenaline increases did not differ between the propranolol and placebo treatment phases. SVRI was inversely associated with fractional increase in plasma adrenaline during both phases. One subject did not faint when on propranolol; this subject's response is discussed in the context of central effects of propranolol. In this small, but tightly controlled, study, propranolol did not prevent tilt-induced vasodilatation, syncope or elevated plasma adrenaline.Keywords
This publication has 45 references indexed in Scilit:
- Sympathoneural and adrenomedullary functional effects of ??2C-adrenoreceptor gene polymorphism in healthy humansPharmacogenetics and Genomics, 2005
- Syncope of psychiatric originClinical Autonomic Research, 2004
- Bench to Bedside: Electrophysiologic and Clinical Principles of Noninvasive Hemodynamic Monitoring Using Impedance CardiographyAcademic Emergency Medicine, 2003
- Is the heart ‘empty’ at syncope?Journal of the Autonomic Nervous System, 1996
- Hemodynamic Mechanism of Vasovagal Syncope.Japanese Heart Journal, 1996
- Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncopeClinical Autonomic Research, 1994
- Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncopeThe American Journal of Cardiology, 1994
- Circulatory control mechanisms in vasodepressor syncopeAmerican Heart Journal, 1982
- Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.Circulation, 1979
- Clinical pharmacology of propranolol.Circulation, 1975